← Back to directory

Anne‐Marie C. Dingemans

Researcher Next ID · RN-033944

Researcher · Medicine

Erasmus MC

Rotterdam, Netherlands

Accepting doctoral researchersFunding unknown
Works count
659
Citation count
21,580
H-index
72
i10-index
266

Research interests

Medicine
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Lung Cancer Diagnosis and Treatment
Neuroendocrine Tumor Research Advances
Radiomics and Machine Learning in Medical Imaging

Publications

  • Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer

    New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2307980

  • Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

    The Lancet · 2023 · 10.1016/s0140-6736(23)00221-0

  • ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

    Annals of Oncology · 2022 · https://doi.org/10.1016/j.annonc.2022.02.003

  • Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    Annals of Oncology · 2021 · 10.1016/j.annonc.2021.03.207

  • Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

    The Lancet Respiratory Medicine · 2020 · https://doi.org/10.1016/s2213-2600(20)30154-5

  • Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective

    European Journal of Cancer · 2020 · 10.1016/j.ejca.2020.06.019

  • COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

    The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30314-4

  • Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

    The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(19)30718-1

  • Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors

    Journal of Thoracic Oncology · 2019 · 10.1016/j.jtho.2019.02.009

  • Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

    Nature Communications · 2019 · 10.1038/s41467-019-11276-9

  • Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report

    Journal of Thoracic Oncology · 2019 · https://doi.org/10.1016/j.jtho.2019.07.025

  • Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome

    Clinical Cancer Research · 2017 · 10.1158/1078-0432.ccr-17-1921

  • The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC

    Journal of Thoracic Oncology · 2016 · 10.1016/j.jtho.2016.10.003

  • Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group

    Thorax · 2015 · 10.1136/thoraxjnl-2014-206677

  • Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

    The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)70168-3

  • Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort

    Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.58.3302

  • Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer

    Oncotarget · 2015 · 10.18632/oncotarget.6279

  • Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)

    Journal of Thoracic Oncology · 2012 · 10.1097/jto.0b013e318262caf6

  • Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan

    Radiotherapy and Oncology · 2009 · 10.1016/j.radonc.2009.03.006

  • Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study

    Annals of Oncology · 2008 · 10.1093/annonc/mdn559

  • Prevalence and Characteristics of Nutritional Depletion in Patients with Stable COPD Eligible for Pulmonary Rehabilitation

    American Review of Respiratory Disease · 1993 · 10.1164/ajrccm/147.5.1151

Current projects

    No projects listed.